valproic acid and capecitabine

valproic acid has been researched along with capecitabine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ibayashi, Y; Jotoku, H; Takahashi, M; Takasaki, M; Tanaka, H; Watanabe, K1
Aloj, L; Avallone, A; Bianco, F; Botti, G; Budillon, A; Caracò, C; Cavalcanti, E; D'Angelo, V; Daniele, G; Delrio, P; Di Gennaro, E; Di Maio, M; Gallo, C; Granata, C; Iaffaioli, VR; Lastoria, S; Maiolino, P; Marone, P; Maurea, N; Montano, M; Muto, P; Pecori, B; Perrone, F; Petrillo, A; Piccirillo, MC; Roca, MS; Romano, G; Silvestro, L; Tatangelo, F; Terranova Barberio, M1
Bruzzese, F; Budillon, A; D'Angelo, G; Di Gennaro, E; Franco, R; Leone, A; Roca, MS; Russo, D; Scogliamiglio, G; Terranova-Barberio, M; Vitagliano, C; Zotti, AI1
Avallone, A; Bruzzese, F; Budillon, A; Delrio, P; Di Gennaro, E; Imbimbo, S; Leone, A; Muto, P; Pecori, B; Roca, MS; Terranova-Barberio, M1

Reviews

1 review(s) available for valproic acid and capecitabine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for valproic acid and capecitabine

ArticleYear
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).
    BMC cancer, 2014, Nov-24, Volume: 14

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Radiotherapy; Rectal Neoplasms; Research Design; Valproic Acid; Young Adult

2014

Other Studies

4 other study(ies) available for valproic acid and capecitabine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
[Effect of capecitabine therapy on the blood levels of antiepileptic drugs - report of two cases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:4

    Topics: Anticonvulsants; Antimetabolites, Antineoplastic; Brain Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug Interactions; Female; Fluorouracil; Humans; Middle Aged; Phenytoin; Seizures; Valproic Acid

2014
Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression.
    Oncotarget, 2016, Feb-16, Volume: 7, Issue:7

    Topics: Animals; Anticonvulsants; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Capecitabine; Cell Proliferation; Chromatin Immunoprecipitation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidine Phosphorylase; Tumor Cells, Cultured; Valproic Acid; Xenograft Model Antitumor Assays

2016
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.
    Journal of experimental & clinical cancer research : CR, 2017, Dec-06, Volume: 36, Issue:1

    Topics: Capecitabine; Colorectal Neoplasms; Flow Cytometry; Humans; Tumor Suppressor Protein p53; Valproic Acid

2017